The BN II System and its nephelometric technology provide uncompromising performance in plasma protein analysis. The menu covers assays to support a variety of clinical indications, such as cardiac risk assessment, kidney diseases, nutritional assessment, and innovative markers as e.g. Cystatin C and Carbohydrate-Deficient Transferrin (CDT).